Crossmark

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment

Crossref DOI link: https://doi.org/10.1186/S40880-019-0413-5

Published: 2019-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Kimura, Hideharu

Amino, Yoshiaki

Koba, Hayato

Tambo, Yuichi

Ohkura, Noriyuki

Hara, Johsuke

Sone, Takashi

Kasahara, Kazuo
Funding

Funding for this research was provided by:

KAKENHI
License Information

Text and Data Mining valid from 2019-11-01
More Information

Article History

Received: 26 June 2019

Accepted: 22 October 2019

First Online: 1 November 2019

Ethics approval and consent to participate

: The ddPCR analysis was conducted according to the protocol approved by the Institutional Review Board of Kanazawa University Graduate School of Medicine (Approved # 327) and conformed to the Declaration of Helsinki.

: Written informed consent for the publication of clinical data and images were obtained from the patient according to the protocol (Approval #327).

: The authors declare that they have no competing interests.